Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cerebrospinal fluid diversion for the treatment of chronic fatigue syndrome and fibromyalgia and use of RNFL thinning as a biomarker therefor

Cerebrospinal fluid diversion for the treatment of chronic fatigue syndrome and fibromyalgia and use of RNFL thinning as a biomarker therefor

US Patent 12151072 · Granted Nov 26, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic applications of artificial cerebrospinal fluid and tools provided th2023
Biomarkers for visual impairment and intracranial pressure (VIIP) syndrome2021
Therapeutic applications of artificial cerebrospinal fluid and tools provided th2020